Ajoy John

Employment

• Christian Medical College & Hospital Assistant Professor
  2018 - Present
• Christian Medical College & Hospital Assistant Professor
  2015 - 2018
• Christian Medical College & Hospital Post Graduate Resident
  2012 - 2015
• Christian Fellowship Community Health Centre Junior Doctor
  2010 - 2012

Education

• Christian Medical College & Hospital
  2004 - 2010

Projects & Funding

Projects & funding information is unavailable.

Publications (23)

• Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III Non–Small Cell Lung Cancer Ineligible for Up-Front Local Therapy: A Propensity Score–Matched Analysis
  JCO Global Oncology 2025 DOI: 10.1200/GO-24-00256
  +Save
• The BRCA mutation spectrum among breast and ovarian cancers in India: highlighting the need to screen BRCA1 185delAG among South Indians
  European Journal of Human Genetics 2024 DOI: 10.1038/s41431-024-01596-w
  +Save
• Randomized Placebo-Controlled Trial of Topical Capsaicin for Delayed Chemotherapy-Induced Nausea and Vomiting
  JCO Global Oncology 2024 DOI: 10.1200/GO.24.00130
  +Save
• Low-dose nivolumab and cabozantinib in recurrent intestinal-type papillary adenocarcinoma of the sinonasal region
  BMJ Case Reports 2023 DOI: 10.1136/bcr-2023-255021
  +Save
• Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer.
  Cancer investigation 2023 DOI: 10.1080/07357907.2023.2278048
  +Save
• Neoadjuvant Versus Adjuvant Systemic Therapy for Early-Stage Non-Small Cell Lung Cancer: The Changing Landscape Due to Immunotherapy.
  The oncologist 2023 DOI: 10.1093/oncolo/oyad125
  +Save
• Total Neoadjuvant Therapy (TNT) with Full Dose Concurrent Chemotherapy in Locally Advanced Rectal Adenocarcinoma Including Signet Ring and Mucinous Cancers.
  Journal of gastrointestinal cancer 2023 DOI: 10.1007/s12029-023-00941-4
  +Save
• Anemia requiring transfusion in breast cancer patients on dose-dense chemotherapy: Prevalence, risk factors, cost and effect on disease outcome
  Supportive Care in Cancer 2022 DOI: 10.1007/s00520-022-06970-2
  +Save
• Neoadjuvant chemotherapy with biosimilar trastuzumab in human epidermal growth factor receptor 2 overexpressed non-metastatic breast cancer: patterns of use and clinical outcomes in India.
  Ecancermedicalscience 2021 DOI: 10.3332/ecancer.2021.1207
  +Save
• Primary mediastinal germ cell tumours: real world experience in the low middle income (LMIC) setting
  ecancermedicalscience 2021 DOI: 10.3332/ecancer.2021.1186
  +Save